Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001593968-20-002048
Filing Date
2020-10-16
Accepted
2020-10-16 12:38:51
Documents
1
Period of Report
2020-06-29

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_01.html 4/A  
1 PRIMARY DOCUMENT primary_01.xml 4/A 6782
  Complete submission text file 0001593968-20-002048.txt   8253
Mailing Address 561 ECCLES AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 561 ECCLES AVENUE SOUTH SAN FRANCISCO CA 94080 (650) 489-9000
RAPT Therapeutics, Inc. (Issuer) CIK: 0001673772 (see all company filings)

EIN.: 473313701 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O RAPT THERAPEUTICS, INC. 561 ECCLES AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address
Robbins Wendye (Reporting) CIK: 0001791244 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-38997 | Film No.: 201243460